Q4 2015 13F Holders as of 31 Dec 2015
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
123,180,519
-
Number of holders
-
86
-
Total 13F shares, excl. options
-
42,424,296
-
Shares change
-
-2,351,821
-
Total reported value, excl. options
-
$103,944,627
-
Value change
-
-$6,424,568
-
Number of buys
-
38
-
Number of sells
-
33
-
Price
-
$2.45
Institutional Holders of CATALYST PHARMACEUTICALS, INC. - COMMON STOCK (CPRX) as of Q4 2015
As of 31 Dec 2015 CATALYST PHARMACEUTICALS, INC. - COMMON STOCK (CPRX) had 101 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 42,424,296 shares of stock of the company.
Largest 10 holders included BAKER BROS. ADVISORS LP, FEDERATED INVESTORS INC /PA/, Broadfin Capital, LLC, Consonance Capital Management LP, VANGUARD GROUP INC, Point72 Asset Management, L.P., FRANKLIN RESOURCES INC, BlackRock Fund Advisors, SPHERA FUNDS MANAGEMENT LTD., and STATE STREET CORP.
This table shows 101 institutional shareholders of the security as of 31 Dec 2015.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.